C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2002
08/29/2002	WO2001007481A9 Antitumor antibodies, proteins, and uses thereof
08/29/2002	WO2000066737A9 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY
08/29/2002	WO2000066709A9 Zymogen activation system
08/29/2002	WO2000063245A9 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
08/29/2002	WO2000034475A9 Grnf4, a gdnf-related neurotrophic factor
08/29/2002	WO2000034474A9 Growth factor homolog zvegf3
08/29/2002	WO2000034447A9 Human ubiquitin ligase e3 for the modulation of nf-kappa b
08/29/2002	WO1999057280A9 Neisseria meningitidis antigens and compositions
08/29/2002	US20020120947 Protein-protein interactions in neurodegenerative disorders
08/29/2002	US20020120123 Human vascular endothelial growth factor 2
08/29/2002	US20020120107 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate
08/29/2002	US20020120103 17 human secreted proteins
08/29/2002	US20020120102 Native Arg-Gly-Asp (RGD) motif has been deleted or has been replaced by an amino acid sequence having no integrin- binding activity, or an integrin-binding amino acid sequence other than RGD which contains aspartic acid or glutamic acid
08/29/2002	US20020119943 Novel mammalian gene,bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes
08/29/2002	US20020119926 Inhibitors of IAPP fibril formation and uses thereof
08/29/2002	US20020119919 Nucleic acids, proteins, and antibodies
08/29/2002	US20020119532 Inoculating, growing Termitomyces clypeatus in sterilized medium containing assimilable carbon source, assimilable nitrogen source and conventional micronutrients at pH 3-7, incubating at 25-30 degrees, filtering
08/29/2002	US20020119530 Method of increasing product expression through solute stress
08/29/2002	US20020119526 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
08/29/2002	US20020119525 TAB1 protein and DNA coding therefore
08/29/2002	US20020119524 Novel molecules of the T129-related protein family and uses thereof
08/29/2002	US20020119519 Nucleotide sequences coding preferential polyeptide for use in the treatment of cancer, kidney and respiratory disorders
08/29/2002	US20020119518 Peptide for use in treatment and diagnosis of heart defects
08/29/2002	US20020119516 Sialylation of saccharides on glycoproteins; obtain glycoprotein, incubate with enzymatic polypeptide, recover adjusted glycoprotein
08/29/2002	US20020119504 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease
08/29/2002	US20020119459 Optical sorting method
08/29/2002	US20020119457 Generating preferential polypeptide; obtain nucleotide sequences, mutate, express nucleotide sequences, separate and recover polypeptide
08/29/2002	US20020119445 Genetic engineering; prophylactic therapy
08/29/2002	US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF
08/29/2002	US20020119149 Multivalent T cell receptor complexes
08/29/2002	US20020119148 ErbB4 antagonists
08/29/2002	US20020119130 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/29/2002	DE10108100A1 Verwendung supersekretierbarer Peptide in Verfahren zu deren Herstellung und paralleler Verbesserung der Exportate eines oder mehrerer anderer Polypeptide von Interesse Use supersekretierbarer peptides in processes for their preparation and parallel improvement of Exportate one or more other polypeptides of interest
08/29/2002	CA2698079A1 A cell therapy method for the treatment of tumors
08/29/2002	CA2438818A1 Rapid production of monoclonal antibodies
08/29/2002	CA2438754A1 A cell therapy method for the treatment of tumors
08/29/2002	CA2438628A1 Artificial proteins with reduced immunogenicity
08/29/2002	CA2438513A1 Modified anti-egfr antibodies with reduced immunogenicity
08/29/2002	CA2438390A1 Methods of modifying eukaryotic cells
08/29/2002	CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
08/29/2002	CA2438245A1 Treatment involving dkk-1 or antagonists thereof
08/29/2002	CA2438235A1 Neurotransmission-associated proteins
08/29/2002	CA2438148A1 Chemically defined medium for cultured mammalian cells
08/29/2002	CA2437161A1 Anti-interferon-.alpha. antibodies
08/29/2002	CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same
08/28/2002	EP1234879A2 Human nucleic acid sequences from prostate tumour tissue
08/28/2002	EP1234574A1 Hair growth stimulant
08/28/2002	EP1234040A2 Hbv sequences
08/28/2002	EP1234038A1 Nucleic acid construct for optimized production of products
08/28/2002	EP1234037A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE
08/28/2002	EP1234035A1 Human cytokine receptor
08/28/2002	EP1234030A2 18 human secreted proteins
08/28/2002	EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies
08/28/2002	EP1233984A2 Insect poison allergens with reduced ige reactivity and method for producing the same
08/28/2002	EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies
08/28/2002	EP1233982A2 Novel hcv non-structural polypeptide
08/28/2002	EP1233981A1 G-protein coupled receptor
08/28/2002	EP1233980A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
08/28/2002	EP1233975A1 29 human secreted proteins
08/28/2002	EP1233974A2 37 staphylococcus aureus genes and polypeptides
08/28/2002	EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies
08/28/2002	EP1141270A4 Ethylene-response-factor1 (erf1) in plants
08/28/2002	EP0942978B1 Methods for producing the anaphase promoting complex
08/28/2002	EP0863990B1 Use of anti-sense sequences to increase responsiveness to gene amplification
08/28/2002	EP0862454B1 Ctla-8 in combination with g-csf or with g-csf and il-6, and use of ctla-8 for treating infections
08/28/2002	EP0827591B1 Method for diagnosing chlamydia using an extracellular biological fluid
08/28/2002	EP0822828B1 Isolated 55 to 75 kda protein which binds to prion protein
08/28/2002	EP0804489B1 Antigenic preparation for treatment or prevention of helicobacter infection
08/28/2002	EP0794966B1 Humanized antibodies to cd38
08/28/2002	CN1366052A Refractory ribosomal protein L-15 gene and its polypeptide coded by it and preparing process
08/28/2002	CN1366049A Chinese bee venom AcHA gene, polypeptide coded by it and its preparing process
08/28/2002	CN1365983A Human alpha interferon derivative with superstrong antiviral activity
08/28/2002	CN1089606C Conjugate between modified superantigen and target-seeking compound and use of conjugate
08/27/2002	US6441157 Grass pollen
08/27/2002	US6441140 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
08/27/2002	US6441138 Protein which induces interferon-γ production by immunocompetent cell
08/27/2002	US6441137 Tie-2 ligands; tie= ?tyrosine kinase with ig (immunoglobulins) and egf (epidermal growth factor) homology domains?; tumor neovascularization
08/27/2002	US6440733 Monoclonal antibodies recognizing antigens on the surface of endothelial cells of tumor vessel
08/27/2002	US6440732 Checkpoint/repair genes involved with dna repair prior to replication; aging resistance; cancer therapy
08/27/2002	US6440730 Retroviral hybrid vectors pseudotyped with LCMV
08/27/2002	US6440727 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
08/27/2002	US6440702 For treatment of motor neuron diseases and muscle degenerative diseases; screening for therapeutic proteins by determining altered electrophoretic binding properties
08/27/2002	US6440701 Transferrin receptor genes of Moraxella
08/27/2002	US6440700 Method of combinatorial protein synthesis based on ribosomal frameshifting
08/27/2002	US6440694 Which is a tumor necrosis factor (tnf) homolog of given nucleotide sequence and amino acid sequence
08/27/2002	US6440693 Given amino acid sequence; recombinant tumor necrosis factor (tnf)-binding protein useful in pharmaceuticals for inhibiting tnf
08/27/2002	US6440680 Using dna encoding the novel prostaglandin receptor and host cells expressing the receptor
08/27/2002	US6440679 Dermatomyositis-specific auto-antigen
08/27/2002	US6440668 Method of DNA shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process
08/27/2002	US6440425 High molecular weight major outer membrane protein of moraxella
08/27/2002	US6440423 Mutant enterotoxin effective as a non-toxic oral adjuvant
08/27/2002	US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy
08/27/2002	US6440407 Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides
08/27/2002	CA2069929C Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
08/27/2002	CA2018592C Polypeptides and polypeptide analogues with inhibitory activity against human elastase
08/23/2002	WO2003102013A2 Methods and compositions for production of recombinant peptides
08/23/2002	CA2444480A1 Methods and compositions for production of recombinant peptides
08/22/2002	WO2002064827A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
08/22/2002	WO2002064811A2 Method for producing recombinant proteins marked with at least one isotope
08/22/2002	WO2002064800A1 Plasmid shuttle vector between escherichia coli and brevibacillus

1 ... 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 ... 1125